Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Mirum Pharmaceuticals Inc (NASDAQ: MIRM) was $40.55 for the day, up 0.62% from the previous closing price of $40.30. In other words, the price has increased by $0.62 from its previous closing price. On the day, 0.51 million shares were traded. MIRM stock price reached its highest trading level at $41.2325 during the session, while it also had its lowest trading level at $39.2595.
Ratios:
Our analysis of MIRM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.47 and its Current Ratio is at 3.68. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 02 ’24 when Howe Jolanda sold 375 shares for $34.00 per share. The transaction valued at 12,750 led to the insider holds 2,426 shares of the business.
Vig Pamela sold 30,559 shares of MIRM for $1,039,006 on Jun 24 ’24. The CHIEF SCIENTIFIC OFFICER now owns 27,406 shares after completing the transaction at $34.00 per share. On Jun 05 ’24, another insider, Ramasastry Saira, who serves as the Director of the company, sold 5,000 shares for $25.68 each. As a result, the insider received 128,400 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 1994236800 and an Enterprise Value of 1904138752. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.53 while its Price-to-Book (P/B) ratio in mrq is 8.13. Its current Enterprise Value per Revenue stands at 8.501 whereas that against EBITDA is -20.405.
Stock Price History:
Over the past 52 weeks, MIRM has reached a high of $44.70, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is 26.52%, while the 200-Day Moving Average is calculated to be 39.84%.
Shares Statistics:
MIRM traded an average of 766.75K shares per day over the past three months and 804920 shares per day over the past ten days. A total of 46.72M shares are outstanding, with a floating share count of 37.89M. Insiders hold about 19.62% of the company’s shares, while institutions hold 102.87% stake in the company. Shares short for MIRM as of 1721001600 were 8174787 with a Short Ratio of 10.66, compared to 1718323200 on 7799965. Therefore, it implies a Short% of Shares Outstanding of 8174787 and a Short% of Float of 20.19.
